Effect of Iranian traditional medicine remedy on chemotherapy induced nausea and vomiting

Phase 2

• Conditions: Condition 1: Nausea and vomiting. Condition 2: Breast cancer. Condition 3: Follow-up examination after chemotherapy for other conditions.; Nausea and vomiting; Breast, unspecified; Follow-up examination after unspecified treatment for other conditions

• Registration Number: IRCT2015061822806N1
• Lead Sponsor: Vice chancellor for research, Mashhad University of Medical Sciences

Brief Summary

???

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 62

Inclusion Criteria

Female, Definitive diagnosis of breast cancer by oncologists and a pathology report by pathologist, Age>18 years, History of chemotherapy induced nausea and vomiting resistant to conventional therapy, Normal tests for CBC, urea, creatinine, Alt, Ast, Bilirubin, FBS, Na, K, Have at least three sessions of chemotherapy ahead.
Exclusion criteria:
Total or upper abdominal radiation therapy along with chemotherapy- Taking anticoagulants, Use of other drugs/therapy for nausea and vomiting that not prescribed in this study, Hypersensitivity to Sumac or Bunium Persicum, Use of sumac and Bunium Persicum in seven days prior to the intervention, Diseases of the digestive system, Diseases that may associate with nausea and vomiting (such as hypertension, liver failure and kidney, digestive problems), Milk allergy, Losing of two consecutive or three intermittent doses of intervention.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of nausea in acute phase. Timepoint: Day 1 of intervention. Method of measurement: questionnaire.;Number of vomiting in acute phase. Timepoint: Day 1 of intervention. Method of measurement: questionnaire.;Severity of nausea in acute phase. Timepoint: Day 1 of intervention. Method of measurement: Visual Analog Scale.;Severity of vomiting in acute phase. Timepoint: Day 1 of intervention. Method of measurement: Visual Analog Scale.

Secondary Outcome Measures

Name	Time	Method
Frequency of nausea in delayed phase. Timepoint: day 2-5 of intervention. Method of measurement: questionnaire.;Frequency of vomiting in delayed phase. Timepoint: day 2-5 of intervention. Method of measurement: questionnaire.;Severity of nausea in delayed phase. Timepoint: day 2-5 of intervention. Method of measurement: Visual Analog Scale.;Severity of vomiting in delayed phase. Timepoint: day 2-5 of intervention. Method of measurement: Visual Analog Scale.